Table 1 Preoperative characteristics
From: Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation
All (n = 349) | Non-TR group (n = 318) | TR group (n = 31) | p | |
|---|---|---|---|---|
Mean age (years) | 52.9 ± 13.3 | 53.0 ± 13.4 | 51.0 ± 12.2 | 0.41 |
Male | 266 (76.2%) | 241 (75.8%) | 25 (80.6%) | 0.54 |
Height (cm) | 174.5 ± 10.3 | 174.4 ± 10.4 | 176.3 ± 9.8 | 0.32 |
Weight (kg) | 86.9 ± 18.9 | 86.0 ± 18.9 | 96.9 ± 16.8 | < 0.01 |
Body mass index | 28.8 ± 5.1 | 28.1 ± 5.0 | 31.3 ± 4.9 | < 0.01 |
Hypertension | 191 (55.0%) | 167 (52.5%) | 24 (77.4%) | < 0.01 |
Dyslipidemia | 112 (32.3%) | 103 (32.4%) | 9 (2.9%) | 0.68 |
Diabetes mellitus | 102 (29.4%) | 92 (28.9%) | 10 (32.3%) | 0.72 |
LVAD | 81 (23.2%) | 72 (22.6%) | 9 (29.0%) | 0.43 |
Nonischemic cardiomyopathy | 244 (69.9%) | 225 (70.8%) | 19 (61.3%) | 0.30 |
Previous cardiac surgery | 168 (48.1%) | 149 (46.9%) | 19 (61.3%) | 0.12 |
Creatinine (mg/dl) | 1.48 ± 1.1 | 1.44 ± 1.0 | 1.48 ± 0.7 | 0.81 |
LVDd (mm) | 65.9 ± 12.8 | 65.7 ± 12.9 | 70.1 ± 12.1 | 0.15 |
Ejection fraction (%) | 24.2 ± 10.9 | 24.2 ± 11.2 | 24.4 ± 6.7 | 0.92 |
CVP (mmHg) | 10.9 ± 6.6 | 10.9 ± 6.6 | 9.7 ± 5.7 | 0.32 |
Mean PAP (mmHg) | 30.4 ± 11.2 | 30.3 ± 11.2 | 30.3 ± 10.7 | 0.98 |
PAWP (mmHg) | 20.3 ± 9.3 | 20.2 ± 9.3 | 19.5 ± 8.7 | 0.68 |
PAPi | 2.84 ± 2.9 | 2.76 ± 2.73 | 3.83 ± 4.4 | 0.07 |
CVP/PAWP | 0.56 ± 0.3 | 0.56 ± 0.3 | 0.51 ± 0.4 | 0.37 |
CI (L/min/m2) | 2.35 ± 0.7 | 2.37 ± 0.7 | 2.15 ± 0.5 | 0.09 |